361 related articles for article (PubMed ID: 17227640)
1. Cervical and oral cancer screening in India.
Sankaranarayanan R; Dinshaw K; Nene BM; Ramadas K; Esmy PO; Jayant K; Somanathan T; Shastri S
J Med Screen; 2006; 13 Suppl 1():S35-8. PubMed ID: 17227640
[TBL] [Abstract][Full Text] [Related]
2. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group.
Sankaranarayanan R; Mathew B; Jacob BJ; Thomas G; Somanathan T; Pisani P; Pandey M; Ramadas K; Najeeb K; Abraham E
Cancer; 2000 Feb; 88(3):664-73. PubMed ID: 10649262
[TBL] [Abstract][Full Text] [Related]
3. Review of screening and preventive strategies for cervical cancer in India.
Patro BK; Nongkynrih B
Indian J Public Health; 2007; 51(4):216-21. PubMed ID: 18232160
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
5. [Model program for screening oral cancers in the Roma population].
Csépe P; Bánóczy J; Dombi C; Forrai J; Gyenes M; Döbrossy L
Magy Onkol; 2007; 51(2):95-101. PubMed ID: 17660865
[TBL] [Abstract][Full Text] [Related]
6. Screening for cervical and oral cancers in India is feasible and effective.
Sankaranarayanan R
Natl Med J India; 2005; 18(6):281-4. PubMed ID: 16483024
[No Abstract] [Full Text] [Related]
7. Human papillomavirus testing for primary cervical cancer screening.
Grce M; Davies P
Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
[TBL] [Abstract][Full Text] [Related]
8. Prevention and early detection of oral, breast and cervical cancers: a practical approach in Indian context.
Nair MK; Varghese C; Mathew B; Sankaranarayanan R
J Indian Med Assoc; 1993 Apr; 91(4):94-6. PubMed ID: 8409491
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
10. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
11. Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India.
Ramadas K; Arrossi S; Thara S; Thomas G; Jissa V; Fayette JM; Mathew B; Sankaranarayanan R
Cancer Detect Prev; 2008; 32(2):109-15. PubMed ID: 18632218
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening in Thailand: an overview.
Sriamporn S; Khuhaprema T; Parkin M
J Med Screen; 2006; 13 Suppl 1():S39-43. PubMed ID: 17227641
[TBL] [Abstract][Full Text] [Related]
13. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India.
Sankaranarayanan R; Ramadas K; Thara S; Muwonge R; Thomas G; Anju G; Mathew B
Oral Oncol; 2013 Apr; 49(4):314-21. PubMed ID: 23265945
[TBL] [Abstract][Full Text] [Related]
14. [The significance of organized screening for uterine cervix cancer in Denmark during 1968-1987].
Lynge E; Engholm G; Madsen M
Ugeskr Laeger; 1992 May; 154(19):1330-4. PubMed ID: 1598705
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
16. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a hospital based cytology screening programme for reduction in life time risk of cervical cancer.
Agarwal SS; Murthy NS; Sharma S; Sharma KC; Das DK
Neoplasma; 1995; 42(2):93-6. PubMed ID: 7617084
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
[TBL] [Abstract][Full Text] [Related]
19. Estimation of reduction of life-time risk of cervical cancer through one life-time screening.
Murthy NS; Agarwal SS; Prabhakar AK; Sharma S; Das DK
Neoplasma; 1993; 40(4):255-8. PubMed ID: 8272152
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
Koong SL; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
